IRIS
RECCHIUTI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.689
AS - Asia 2.101
EU - Europa 1.885
Continente sconosciuto - Info sul continente non disponibili 390
SA - Sud America 230
AF - Africa 51
OC - Oceania 10
Totale 8.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.575
SG - Singapore 901
CN - Cina 502
IT - Italia 374
IE - Irlanda 250
SE - Svezia 222
VN - Vietnam 222
RU - Federazione Russa 221
UA - Ucraina 186
BR - Brasile 171
GB - Regno Unito 163
TR - Turchia 148
DE - Germania 138
IN - India 111
FR - Francia 107
CA - Canada 59
FI - Finlandia 56
AT - Austria 46
HK - Hong Kong 45
BD - Bangladesh 40
PL - Polonia 29
AR - Argentina 27
MX - Messico 26
JP - Giappone 23
NL - Olanda 21
KR - Corea 19
ZA - Sudafrica 16
ES - Italia 15
BE - Belgio 14
BZ - Belize 13
EG - Egitto 13
IQ - Iraq 12
AU - Australia 9
IL - Israele 9
IR - Iran 9
PK - Pakistan 9
CO - Colombia 8
LT - Lituania 8
PH - Filippine 7
AZ - Azerbaigian 6
CL - Cile 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
ID - Indonesia 6
SA - Arabia Saudita 6
KE - Kenya 5
PT - Portogallo 5
UZ - Uzbekistan 5
VE - Venezuela 5
BY - Bielorussia 4
DZ - Algeria 4
MA - Marocco 4
RO - Romania 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
GE - Georgia 3
HR - Croazia 3
JM - Giamaica 3
PE - Perù 3
RS - Serbia 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
EU - Europa 1
FJ - Figi 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
LY - Libia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
SI - Slovenia 1
SV - El Salvador 1
Totale 7.967
Salva come PNG Salva come JPEG
Città #
Singapore 684
San Jose 417
Chandler 366
Ashburn 299
Dublin 248
Jacksonville 229
Council Bluffs 156
Beijing 139
Dallas 138
New York 132
Princeton 110
Dearborn 94
Southend 88
Santa Clara 80
Izmir 77
Los Angeles 75
Ann Arbor 74
Ho Chi Minh City 69
The Dalles 69
Wilmington 66
Nanjing 62
Boardman 56
Pescara 55
Hanoi 52
Chieti 47
Altamura 41
Rome 39
Houston 35
Vienna 35
Tongling 34
Woodbridge 32
Hong Kong 31
Phoenix 29
Cambridge 28
Montreal 28
Buffalo 27
Hefei 26
Redondo Beach 26
Washington 26
Augusta 23
Brooklyn 23
Munich 23
Nuremberg 23
Warsaw 23
San Mateo 22
Columbus 21
Moscow 21
Nanchang 21
São Paulo 21
Tokyo 20
Helsinki 18
Dong Ket 17
Toronto 16
Chennai 15
Denver 15
Milan 15
Brussels 13
Frankfurt am Main 13
Johannesburg 13
Naples 13
Orem 13
Central 12
Falls Church 12
Mexico City 12
Ancona 11
Cairo 11
Lappeenranta 11
Seattle 11
Shenyang 11
Tianjin 11
Amsterdam 10
Ankara 10
Chicago 10
Jiaxing 10
San Francisco 10
Boston 9
New Delhi 9
Seoul 9
Shanghai 9
Ascoli Piceno 8
Poplar 8
Stockholm 8
Da Nang 7
Kunming 7
London 7
Manchester 7
Baku 6
Changsha 6
Düsseldorf 6
Haiphong 6
Hangzhou 6
Jinan 6
Prato 6
Redwood City 6
Atlanta 5
Falkenstein 5
Hebei 5
Hải Dương 5
Jundiaí 5
Melbourne 5
Totale 5.039
Salva come PNG Salva come JPEG
Nome #
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 218
Establishment and long-term culture of human cystic fibrosis endothelial cells 203
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 203
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 198
Mechanisms of endothelial cell dysfunction in cystic fibrosis 191
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 168
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. 167
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 167
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 166
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 164
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 161
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 151
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. 150
Epigenetic regulation of the formyl peptide receptor 2 gene 150
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 148
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 147
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 147
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 146
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 145
Lipoxins, resolvins, and the resolution of inflammation 142
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 141
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 141
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 141
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 140
Lipoxin receptors 137
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. 135
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 135
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. 134
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. 134
Homocysteine modulates the CD40/CD40L system 132
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 132
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 130
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 130
Novel anti-inflammatory--pro-resolving mediators and their receptors. 128
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 128
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 122
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. 119
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 119
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. 117
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 117
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 114
Targeting caveolin-1 deficiency in bone marrow derived cells: A new therapeutic window for fibrotic diseases? 110
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 109
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 108
RESOLVINS, LIPOXINS, AND MARESINS IN RESOLUTION OF INFLAMMATION 107
17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease 104
Resolvin D1 and its GPCRs in resolution circuits of inflammation. 104
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 104
The Resolution Approach to Cystic Fibrosis Inflammation 104
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 95
Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease 94
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 93
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 89
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 85
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 83
Specialized pro-resolving lipid mediators and resolution of viral diseases 82
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 81
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 81
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer 76
Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease 75
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 74
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 73
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 72
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis 70
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 70
Nrf2 Plays a Key Role in Erythropoiesis during Aging 54
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES 48
Development and application of a multimatrix LC-MS/MS method for quantifying elexacaftor-tezacaftor-ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat 33
17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized mice 16
The diadenosine tetraphosphate hydrolase ApaH contributes to Pseudomonas aeruginosa pathogenicity 4
Totale 8.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022329 0 0 2 88 15 11 6 22 19 15 26 125
2022/2023958 72 133 61 105 88 170 49 64 146 12 32 26
2023/2024649 54 32 37 26 35 193 97 55 7 29 19 65
2024/20251.408 74 241 147 53 85 68 90 106 122 83 155 184
2025/20262.870 254 99 236 351 309 169 548 128 309 269 145 53
2026/2027280 45 153 82 0 0 0 0 0 0 0 0 0
Totale 8.356